119 related articles for article (PubMed ID: 3735805)
1. Effect of injection of CCK-8 into the nucleus caudatus on the behavior of rats.
Takeda Y; Kamiya Y; Honda K; Takano Y; Kamiya H
Jpn J Pharmacol; 1986 Apr; 40(4):569-75. PubMed ID: 3735805
[TBL] [Abstract][Full Text] [Related]
2. Cholecystokinin potentiates dopamine-mediated behaviors: evidence for modulation specific to a site of coexistence.
Crawley JN; Stivers JA; Blumstein LK; Paul SM
J Neurosci; 1985 Aug; 5(8):1972-83. PubMed ID: 4040554
[TBL] [Abstract][Full Text] [Related]
3. Behavioral evidence for cholecystokinin modulation of dopamine in the mesolimbic pathway.
Crawley JH
Prog Clin Biol Res; 1985; 192():131-8. PubMed ID: 4080706
[TBL] [Abstract][Full Text] [Related]
4. Role of dopaminergic and GABAergic mechanisms in discrete brain areas in phencyclidine-induced locomotor stimulation and turning behavior.
Yamaguchi K; Nabeshima T; Kameyama T
J Pharmacobiodyn; 1986 Dec; 9(12):975-86. PubMed ID: 3033192
[TBL] [Abstract][Full Text] [Related]
5. Sedative action of cholecystokinin octapeptide on behavioral excitation by thyrotropin releasing hormone and methamphetamine in the rat.
Katsuura G; Itoh S
Jpn J Physiol; 1982; 32(1):83-91. PubMed ID: 6281507
[TBL] [Abstract][Full Text] [Related]
6. Cholecystokinin facilitates methamphetamine-induced dopamine overflow in rat striatum and fetal ventral mesencephalic grafts.
Wang Y; Perng SL; Lin JC; Tsao WL
Exp Neurol; 1994 Dec; 130(2):279-87. PubMed ID: 7867757
[TBL] [Abstract][Full Text] [Related]
7. Specificity of nucleus accumbens to activities related to cholecystokinins in rats.
Katsuura G; Itoh S; Hsiao S
Peptides; 1985; 6(1):91-6. PubMed ID: 3991366
[TBL] [Abstract][Full Text] [Related]
8. In rats, the behavioral profile of CCK-8 related peptides resembles that of antipsychotic agents.
Van Ree JM; Gaffori O; De Wied D
Eur J Pharmacol; 1983 Sep; 93(1-2):63-78. PubMed ID: 6138272
[TBL] [Abstract][Full Text] [Related]
9. Influence of cholecystokinin on central monoaminergic pathways.
Widerlöv E; Kalivas PW; Lewis MH; Prange AJ; Breese GR
Regul Pept; 1983 May; 6(2):99-109. PubMed ID: 6308717
[TBL] [Abstract][Full Text] [Related]
10. Effects of cholecystokinin octapeptide on striatal dopamine metabolism and on apomorphine-induced stereotyped cage-climbing in mice.
Kovács GL; Szabó G; Penke B; Telegdy G
Eur J Pharmacol; 1981 Jan; 69(3):313-9. PubMed ID: 6260512
[TBL] [Abstract][Full Text] [Related]
11. Antipsychotic substances and dopamine in the rat brain; behavioral studies reveal distinct dopamine receptor systems.
Van Ree JM; Elands J; Király I; Wolterink G
Eur J Pharmacol; 1989 Aug; 166(3):441-52. PubMed ID: 2572429
[TBL] [Abstract][Full Text] [Related]
12. Effects of unilateral intracerebroventricular microinjections of cholecystokinin (CCK) on circling behavior of rats.
Morency MA; Ross GM; Hesketh D; Mishra RK
Peptides; 1987; 8(6):989-95. PubMed ID: 3441450
[TBL] [Abstract][Full Text] [Related]
13. Sulpiride injection into the dorsal striatum increases methamphetamine-induced gnawing in rats.
Koshikawa N; Aoki S; Tomiyama K; Maruyama Y; Kobayashi M
Eur J Pharmacol; 1987 Jan; 133(1):119-25. PubMed ID: 3556388
[TBL] [Abstract][Full Text] [Related]
14. The locomotor and stereotype response to dopaminergic drugs and caffeine after intracerebroventricular kainic acid in rats.
Kleinrok Z; Turski L; Wawrzyniak M; Cybulska R
Pol J Pharmacol Pharm; 1981; 33(2):149-59. PubMed ID: 7198226
[TBL] [Abstract][Full Text] [Related]
15. Bromocriptine enhances the behavioural effects of apomorphine and dopamine after systemic or intracerebral injection in rats.
Jenkins OF; Jackson DM
Neuropharmacology; 1986 Nov; 25(11):1243-9. PubMed ID: 3796797
[TBL] [Abstract][Full Text] [Related]
16. Substance P and cholecystokinin regulate neurochemical responses to cocaine and methamphetamine in the striatum.
Loonam TM; Noailles PA; Yu J; Zhu JP; Angulo JA
Life Sci; 2003 Jun; 73(6):727-39. PubMed ID: 12801594
[TBL] [Abstract][Full Text] [Related]
17. Altered responding to cholecystokinins and dopaminergic agonists following 6-hydroxydopamine treatment in rats.
Hsiao S; Katsuura G; Itoh S
Behav Neurosci; 1985 Oct; 99(5):853-60. PubMed ID: 3939625
[TBL] [Abstract][Full Text] [Related]
18. Dopamine receptors and ergot drugs. Evidence that an ergolene derivative is a differential agonist at subcortical limbic dopamine receptors.
Fuxe K; Fredholm BB; Agnati LF; Corrodi H
Brain Res; 1978 May; 146(2):295-311. PubMed ID: 647392
[TBL] [Abstract][Full Text] [Related]
19. Methamphetamine-induced behavioral alterations following repeated administration of methamphetamine.
Yamanaka Y; Takano R; Egashira T
Jpn J Pharmacol; 1986 Jun; 41(2):147-54. PubMed ID: 3091891
[TBL] [Abstract][Full Text] [Related]
20. Asymmetry in behavioral responses to cholecystokinin microinjected into rat nucleus accumbens and amygdala.
Belcheva I; Belcheva S; Petkov VV; Petkov VD
Neuropharmacology; 1994 Aug; 33(8):995-1002. PubMed ID: 7845556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]